Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Insomnia Market?

The market size for insomnia has seen consistent growth in previous years. It’s predicted to expand from $5 billion in 2024 to $5.24 billion in 2025, marking a compound annual growth rate (CAGR) of 4.7%. This growth over the historic period is largely due to rising stress levels, the prevalence of mental health issues, erratic working shifts and irregular working hours, heightened awareness and diagnosis, and a high intake of stimulants.

What Growth Rate Is Forecasted for the Insomnia Market by 2029?

Strong expansion is anticipated in the insomnia market size in the forthcoming years. The market is projected to reach $6.62 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. The projected growth in this period can be linked to the impact of the global health crisis, the rise in sleep hygiene awareness, stress on mental health and wellness, sleep health directives implemented by the government, and influence of social determinants. Main trends for the forecast period are digital solutions for sleep monitoring, cognitive behavioral therapy for insomnia, telemedicine for sleep related consultations, inclusion of sleep health in primary healthcare, and exploration of novel therapeutic targets.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp

Which Key Companies Are Shaping the Future of the Insomnia Market?

Major companies operating in the insomnia market include Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

Which Factors Are Driving Demand in the Insomnia Industry?

The rise in occupational stress is anticipated to drive the expansion of the insomnia industry. Occupational stress pertains to detrimental emotional and physiological responses arising from disparities between job requirements, demands, and an employee’s resources, abilities, or understanding. This form of stress can adversely affect health, triggering conditions such as insomnia. The treatment for insomnia varies and could involve medication or cognitive-behavioral therapies, among others, based on the severity. Therefore, the increment in work-related stress stimulates sales in the insomnia market. As per the American Psychological Association, a US-based psychologists’ association, in October 2022, 77% of workers reported experiencing work-related stress in the preceding month, reiterating that workplace stress remains a prominent problem. Moreover, about 57% mentioned encountering negative impacts such as emotional exhaustion (31%), which are typically associated with workplace burnout. Thus, the escalating trend in work-related stress spurs the growth of the insomnia sector.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12120&type=smp

How Is the Insomnia Market Segmented by Several Divisions?

The insomnia market covered in this report is segmented –

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy

2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy

2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements

What are the Emerging Market Trends Driving the Growth of the Insomnia Industry?

Product innovation is emerging as a crucial trend in the insomnia market. Leading businesses in the therapeutics sector for insomnia are creating groundbreaking treatments to maintain their market presence. For example, in April 2023, the Ministry of Food and Drug Safety (MFDS) approved WELT, a medical device company based in Korea, for its digital insomnia treatment device called WELT-I. The device was identified as a medical innovation designed to rectify behavioral, psychological, and cognitive factors that exacerbate or maintain insomnia. The WELT-I device offers treatment centred on cognitive behavioral therapy (CBT), which is recommended as an initial treatment option in clinical guidelines for insomnia. The device falls under the category of a software as a medical device (SaMD), it works to enhance insomnia through customized sleep duration strategies, examining sleep disruption patterns, intervening in patient behavior to improve sleep quality, and administering relaxation therapy for a period of eight weeks to alleviate tension and stress.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Which Regions Are Driving Growth in the Insomnia Market?

North America was the largest region in the insomnia market in 2024. The regions covered in the insomnia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12120

This Report Delivers Insight On:

1. How big is the insomnia market, and how is it changing globally?

2. Who are the major companies in the insomnia market, and how are they performing?

3. What are the key opportunities and risks in the insomnia market right now?

4. Which products or customer segments are growing the most in the insomnia market?

5. What factors are helping or slowing down the growth of the insomnia market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model